United States· US:57896-443_41d6e645-b654-726f-e063-6394a90a101b
Bisacodyl
A medicinal product containing bisacodyl, registered in United States by GERI-CARE PHARMACEUTICAL CORP.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BISACODYL
- Manufacturer
- GERI-CARE PHARMACEUTICAL CORP
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11578964430120 BLISTER PACK in 1 CARTON (57896-443-01) / 5 SUPPOSITORY in 1 BLISTER PACK (57896-443-55)
- ndc11578964430510 BLISTER PACK in 1 CARTON (57896-443-05) / 5 SUPPOSITORY in 1 BLISTER PACK (57896-443-55)
- ndc1157896443122 BLISTER PACK in 1 CARTON (57896-443-12) / 6 SUPPOSITORY in 1 BLISTER PACK (57896-443-66)
- ndc1157896-443-01
- ndc1157896-443-05
- ndc1157896-443-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bisacodyl in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandBisacodyl GSKPharmapoint SA
- CzechiaDULCOLAXOpella Healthcare Czech s.r.o., Praha
- CanadaAMB-BISACODYLAMBICARE PHARMACEUTICALS INC.
- NetherlandsBisacodyl zetpil CF 10 mg, zetpillenCentrafarm B.V.
- FranceDULCOLAX 10 mg, suppositoireOPELLA HEALTHCARE FRANCE
- IrelandDulcolax 10 mg SuppositoriesOpella Healthcare France SAS T/A Sanofi
- NorwayDulcolaxOpella Healthcare France SAS
- SpainDULCOLAX BISACODILO 10 MG SUPOSITORIOSOpella Healthcare Spain S.L.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dulcolax, Laxbene
- Belgium · Bisacodyl Eg, Bisacodyl Teva
- Bulgaria · Бизакодил Софарма, Бизалакс
- Cyprus · Dulcolax, Lax-Tab
- Czechia · Bisacodyl Krka, Dulcolax
- Germany · Bekunis Dragees, Bisacodyl Adgc Laxans
- Denmark · Dulcolax, Toilax
- Estonia · Bisacodyl Grindeks
- Spain · Bekunis, Dulcolax
- Finland · Toilax, Toilax Kombinationsförpackning
- France · Bisacodyl Arrow Conseil, Bisacodyl Biogaran Conseil
- United Kingdom (Northern Ireland) · Biolax, Biolax 12 Years Plus
- Greece · Dulcolax
- Croatia · Dulcolax
- Hungary · Dulcolax, Stadalax
- Ireland · Dulcolax
- Iceland · Dulcolax, Toilax
- Italy · Alaxa, Confetto C.M.
- Lithuania · Bisacodyl Grindeks, Bisacodyl Viatris
- Luxembourg · Dulcolax, Purgo-Pil
- Latvia · Bisacodyl, Bisacodyl Grindeks
- Malta · Dulcolax, Lax-Tab
- Netherlands · Bisacodyl Aurobindo, Bisacodyl Leidapharm
- Norway · Dulcolax, Toilax
- Poland · Bisacodyl Pharmaswiss, Dulcobis
- Portugal · Aero-Om Laxante, Bekunis Laxante Bisacodil
- Romania · Bisacodil Arena, Bisacodil Laropharm
- Sweden · Dulcolax, Toilax
- Slovenia · Dulcolax, Novolax
- Slovakia · Bisacodyl-K, Dulcolax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/534b67bb-ed88-46f5-98a1-3c5d6b831604 GET /v1/drugs/534b67bb-ed88-46f5-98a1-3c5d6b831604?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RECTAL",
"source": "ndc",
"strength": "10",
"substance": "BISACODYL",
"productndc": "57896-443",
"dosage_form": "SUPPOSITORY",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "505G(a)(3)",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about bisacodyl.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.